Related Experiment Video
Updated: Apr 27, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Neuroadaptive changes associated with smoking: structural and functional neural changes in nicotine dependence
1Department of Clinical Psychology, University of Fribourg, CH-1700 Fribourg, Switzerland. chantal.martinsoelch@unifr.ch.
This review explores neuroadaptive changes in human smokers, linking addiction to reinforcement, dopamine, and stress systems. Understanding these brain changes is key for developing effective treatments for nicotine dependence.
Area of Science:
- Neuroscience
- Addiction Research
- Psychiatry
Background:
- Tobacco smoking is a prevalent form of substance abuse.
- Addiction models involve positive and negative reinforcement mechanisms.
- Neurobiological stress and reward systems are implicated in substance abuse.
Purpose of the Study:
- To review neuroadaptive changes in human smokers.
- To align findings with current neurobiological models of addiction.
- To identify targets for nicotine dependence treatment.
Main Methods:
- Review of neurobiological models of addiction.
- Analysis of neuroadaptive changes in human smokers.
- Examination of the role of dopamine, reinforcement, and cognitive control.
Main Results:
- Nicotine addiction involves striatal dopamine release (positive reinforcement) and stress system activation (negative reinforcement).
- Drug-related stimuli gain motivational control, contributing to relapse.
- Chronic use leads to blunted responses to natural rewards and activated anti-reward systems.
- Reduced inhibitory cognitive control supports addiction development and maintenance.
Conclusions:
- Neuroadaptive changes in nicotine dependence align with established addiction models.
- Further research is needed to elucidate specific neuroadaptive changes for treatment development.
- Understanding these neural mechanisms is crucial for effective nicotine dependence interventions.
More Related Videos
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Dependence
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Alzheimer Disease ll: Pathophysiology

